These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16470150)

  • 1. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for chronic rejection in heart and lungs--why do hearts and lungs rot?
    Wallwork J
    Clin Transplant; 1994 Jun; 8(3 Pt 2):341-4. PubMed ID: 8061378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of coronary artery pathologic findings in human cardiac allografts.
    Johnson DE; Gao SZ; Schroeder JS; DeCampli WM; Billingham ME
    J Heart Transplant; 1989; 8(5):349-59. PubMed ID: 2795279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.
    Hosenpud JD; Shipley GD; Wagner CR
    J Heart Lung Transplant; 1992; 11(1 Pt 1):9-23. PubMed ID: 1540617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts.
    Haddad M; Pflugfelder PW; Guiraudon C; Novick RJ; McKenzie FN; Menkis A; Kostuk WJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1218-25. PubMed ID: 16143236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplant coronary disease: nonimmunologic risk factors.
    Johnson MR
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S124-32. PubMed ID: 1622991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and etiology of chronic rejection of the heart.
    Billingham ME
    Clin Transplant; 1994 Jun; 8(3 Pt 2):289-92. PubMed ID: 8061370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of combined heart and kidney transplantation: a French multicenter study.
    Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
    J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
    Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic features in long-term cardiac allografts.
    Pucci AM; Forbes RD; Billingham ME
    J Heart Transplant; 1990; 9(4):339-45. PubMed ID: 2398426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
    Kocík M; Málek I; Janek B; Zelízko M; Pirk J
    Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL
    J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury.
    Day JD; Rayburn BK; Gaudin PB; Baldwin WM; Lowenstein CJ; Kasper EK; Baughman KL; Baumgartner WA; Hutchins GM; Hruban RH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S142-9. PubMed ID: 8719476
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerated graft coronary artery disease: diagnosis and prevention.
    Schroeder JS; Gao SZ; Hunt SA; Stinson EB
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S258-65. PubMed ID: 1515448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart transplantation--indications and results].
    Loebe M; Hetzer R; Schüler S; Hummel M; Friedel N; Weng Y; Schiessler A
    Zentralbl Chir; 1992; 117(12):681-8. PubMed ID: 1285476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation.
    Kübrich M; Petrakopoulou P; Kofler S; Nickel T; Kaczmarek I; Meiser BM; Reichart B; von Scheidt W; Weis M
    Transplantation; 2008 Jun; 85(11):1580-7. PubMed ID: 18551063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.